2017
Outcomes of Transcatheter Tricuspid Valve-in-Valve Implantation in Patients With Ebstein Anomaly
Taggart NW, Cabalka AK, Eicken A, Aboulhosn JA, Thomson JDR, Whisenant B, Bocks ML, Schubert S, Jones TK, Asnes JD, Fagan TE, Meadows J, Hoyer M, Martin MH, Ing FF, Turner DR, Latib A, Tzifa A, Windecker S, Goldstein BH, Delaney JW, Kuo JA, Foerster S, Gillespie M, Butera G, Shahanavaz S, Horlick E, Boudjemline Y, Dvir D, McElhinney DB, Registry V. Outcomes of Transcatheter Tricuspid Valve-in-Valve Implantation in Patients With Ebstein Anomaly. The American Journal Of Cardiology 2017, 121: 262-268. PMID: 29153244, DOI: 10.1016/j.amjcard.2017.10.017.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedBioprosthesisCardiac CatheterizationEbstein AnomalyEndocarditisFemaleHeart Valve ProsthesisHeart Valve Prosthesis ImplantationHumansMaleMiddle AgedPostoperative ComplicationsProsthesis FailureRegistriesReoperationThrombosisTreatment OutcomeTricuspid ValveTricuspid Valve InsufficiencyYoung AdultConceptsEbstein's anomalyValve dysfunctionValve implantationTricuspid valveAcute valve thrombosisMedium-term durabilityPatient underwent reinterventionPatient-prosthesis mismatchSevere tricuspid regurgitationTranscatheter Tricuspid ValveNYHA statusProcedural mortalityTranscatheter tricuspidUnderwent reinterventionMelody valveValve thrombosisMost patientsTricuspid regurgitationCommon indicationAcute resultsSurgical bioprosthesesInternational registryInvasive alternativePatientsTVIV
2016
Transcatheter Tricuspid Valve-in-Valve Implantation for the Treatment of Dysfunctional Surgical Bioprosthetic Valves
McElhinney DB, Cabalka AK, Aboulhosn JA, Eicken A, Boudjemline Y, Schubert S, Himbert D, Asnes JD, Salizzoni S, Bocks ML, Cheatham JP, Momenah TS, Kim DW, Schranz D, Meadows J, Thomson JD, Goldstein BH, Crittendon I, Fagan TE, Webb JG, Horlick E, Delaney JW, Jones TK, Shahanavaz S, Moretti C, Hainstock MR, Kenny DP, Berger F, Rihal CS, Dvir D. Transcatheter Tricuspid Valve-in-Valve Implantation for the Treatment of Dysfunctional Surgical Bioprosthetic Valves. Circulation 2016, 133: 1582-1593. PMID: 26994123, DOI: 10.1161/circulationaha.115.019353.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAged, 80 and overBioprosthesisCardiac CatheterizationChildChild, PreschoolFemaleFollow-Up StudiesHeart Valve Prosthesis ImplantationHumansInternationalityLength of StayMaleMiddle AgedProsthesis FailureRegistriesTreatment OutcomeTricuspid Valve InsufficiencyYoung AdultConceptsNew York Heart Association class IIIClass IIITV dysfunctionValve implantationNew York Heart Association class IValve sizePulmonary valve prosthesisTricuspid regurgitation gradePatient-related factorsSurgical bioprosthetic valvesTranscatheter Tricuspid ValveTV reinterventionsMulticenter registrySAPIEN valveMedian ageRegurgitation gradeSerious complicationsClinical statusTricuspid valveLabel useTranscatheter prosthesesBioprosthetic valvesValve prosthesisPatientsValve bioprostheses